Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.


BWXT Awarded $35 Million in Uranium Processing and Research Reactor Fuel Contracts

11 March 2021

(LYNCHBURG, Va. – March 11, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Nuclear Operations Group, Inc. (BWXT NOG) subsidiary has been awarded a total of $35 million in contracts under two separate programs – uranium recovery and conversion as well as construction of a new research reactor fuel line.

“These awards showcase BWXT’s unique capabilities in processing and manufacturing nuclear fuels, our long history fueling research reactors and our dedication to enhancing global security,” said BWXT NOG President Joel W. Duling. 

Uranium recovery and conversion

The U.S. Naval Nuclear Propulsion Program has awarded BWXT NOG a $17.4 million contract for uranium recovery and conversion. An additional option is expected to be awarded later this year.

This contract funds the recovery of valuable uranium from scrap, waste and unused product to be converted into fuel to feed future Naval Nuclear Propulsion Program products. BWXT owns the only two Category 1 nuclear facilities licensed by the Nuclear Regulatory Commission to store and process highly enriched uranium.

This work began at the BWXT NOG facility in Lynchburg, Virginia in January 2021 and is expected to be completed by June 2022.

HALEU research reactor fuel project

The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) awarded a $17.9 million contract to BWXT NOG to complete the second phase of the construction of a new research reactor fuel line BWXT previously announced.

The contract funds the repurposing of a portion of the Lynchburg uranium processing facility to be used to manufacture uranium-molybdenum alloy High Assay Low Enriched Uranium (U-Mo HALEU) fuel. This fuel will facilitate conversion of high-performance U.S. research reactors that currently use high enriched uranium. The NNSA has encouraged the conversion of research reactors and medical isotope production facilities from the use of high enriched uranium to reduce the risk of the fuel being diverted for nefarious purposes.

BWXT has been supplying fuel elements and assemblies manufactured in Lynchburg for research and test reactors for decades and is the only North American supplier of fuel-bearing components for reactors at national laboratories, colleges and universities.


Forward Looking Statements

BWXT cautions that this release contains forward-looking statements, including statements relating to the performance, timing, impact and value, to the extent contract value can be viewed as an indicator of future revenues, of the contracts for uranium recovery and conversion and second phase of the nonproliferation research reactor fuel program; the exercise of any option awards; and the timing, benefits and impact of the foregoing. These forward-looking statements involve a number of risks and uncertainties, including, among other things, modification or termination of the contracts and/or options and delays in production of or limited demand for U-Mo HALEU. If one or more of these or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, please see BWXT’s annual report on Form 10-K for the year ended December 31, 2020. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.


About BWXT

At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. Headquartered in Lynchburg, Virginia, BWXT provides safe and effective nuclear solutions for national security, clean energy, environmental remediation, nuclear medicine and space exploration. With approximately 6,700 employees, BWXT has 12 major operating sites in the U.S. and Canada. In addition, BWXT joint ventures provide management and operations at more than a dozen U.S. Department of Energy and NASA facilities. Follow us on Twitter at @BWXTech and learn more at www.bwxt.com.


Media Contact                                                

Chris Dumond
Communications Manager                   

Investor Contact

Mark Kratz
Director, Investor Relations

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800

BWXT Canada Ltd.
BWXT Nuclear Energy Canada Inc.
BWXT Medical Ltd.

Monifa Miller
+1 519.242.8071

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141